Immunic, Inc.

IMUX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001280776

SEC filings (opens in a new tab)

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Immunic, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of IMUX: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	69	82	+13
Shares	13.7M	17.6M	+3.90M (+28.4%)
Value	$131.1M	$199.0M	+$67.8M (+51.7%)

New holders (17)

Institutions that held Immunic, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to IMUX in Q1 2022
Institution	Shares	Value	% of portfolio
Commodore Capital LP	893,013	$10.1M	2.25%
Pura Vida Investments, LLC	683,287	$7.72M	0.93%
Janus Henderson Group PLC	332,989	$3.76M	0.00%
J. Goldman & Co LP	101,500	$1.15M	0.09%
Norges Bank	84,100	$950.3K	0.00%
Silverarc Capital Management, LLC	68,475	$774.0K	0.42%
D. E. Shaw & Co., Inc.	65,825	$744.0K	0.00%
DLD Asset Management, LP	50,000	$565.0K	0.04%
SG3 Management, LLC	20,903	$236.0K	0.07%
Susquehanna International Group, LLP	12,920	$146.0K	0.00%
MetLife Investment Management	11,878	$134.2K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	3,031	$34.0K	0.00%
Amalgamated Bank	2,264	$26.0K	0.00%
Amalgamated Financial Corp.	2,264	$26.0K	0.00%
Metropolitan Life Insurance Co	1,392	$15.7K	0.00%
Point72 Hong Kong Ltd	504	$6.00K	0.00%
Cubist Systematic Strategies, LLC	44	$0	0.00%

Sold out (4)

Institutions that held Immunic, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of IMUX in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Ghost Tree Capital, LLC	165,000	$1.58M
Engineers Gate Manager LP	11,629	$111.0K
Manufacturers Life Insurance Company, The	10,029	$96.0K
Marshall Wace, LLP	2,432	$24.0K